Skip to main content
. 2017 May 19;7:2203. doi: 10.1038/s41598-017-02294-y

Table 3.

The relative concentrations of 16 plasma miRNAs chosen from TLDA determined by RT-qPCR assay for the SE, MH and MS protocols.

miRNA SE MH MS
Pre 0 h 1 h 24 h Pre 0 h 1 h 24 h Pre 0 h 1 h 24 h
miR-1 0.14 ± 0.02 0.17 ± 0.05 0.22 ± 0.04 0.12 ± 0.03 0.24 ± 0.05 0.19 ± 0.05 0.23 ± 0.05 0.33 ± 0.13 0.27 ± 0.06 0.24 ± 0.04 0.31 ± 0.06 0.29 ± 0.06
miR-133a 0.46 ± 0.09 0.46 ± 0.17 0.46 ± 0.11 0.43 ± 0.15 0.33 ± 0.04 0.17 ± 0.55* 0.33 ± 0.06 0.28 ± 0.04 1.34 ± 0.30 0.90 ± 0.19* 1.22 ± 0.27 1.17 ± 0.36
miR-133b 0.11 ± 0.02 0.12 ± 0.02 0.14 ± 0.03 0.11 ± 0.01 0.10 ± 0.01 0.08 ± 0.01 0.12 ± 0.04 0.14 ± 0.02 0.13 ± 0.02 0.11 ± 0.01 0.14 ± 0.02 0.11 ± 0.01
miR-146a 4.01 ± 0.21 3.65 ± 0.10 6.23 ± 2.01) 4.17 ± 1.07 1.63 ± 0.38 1.15 ± 0.25 1.01 ± 0.21 1.26 ± 0.22 1.99 ± 0.31 2.33 ± 0.09 2.15 ± 0.10 1.79 ± 0.18
miR-181a 0.1 ± 0.02 0.08 ± 0.02 0.09 ± 0.01 0.07 ± 0.01 0.07 ± 0.02 0.07 ± 0.02 0.12 ± 0.03*,† 0.06 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 0.07 ± 0.01 0.05 ± 0.01
miR-21 5.87 ± 0.67 4.35 ± 1.28 6.77 ± 0.99 4.89 ± 0.75 5.66 ± 0.79 3.93 ± 0.71* 6.62 ± 1.00 5.17 ± 1.10 3.37 ± 0.63 3.03 ± 0.53 3.16 ± 0.52 2.63 ± 0.37
miR-205 0.08 ± 0.01 0.06 ± 0.01 0.08 ± 0.01 0.08 ± 0.02 0.10 ± 0.01 0.12 ± 0.05 0.10 ± 0.01 0.10 ± 0.01 0.13 ± 0.02 0.13 ± 0.01 0.15 ± 0.02 0.14 ± 0.02
miR-206 14.6 ± 2.32 13.1 ± 2.63 16.9 ± 3.23 13.1 ± 3.31 11.6 ± 1.60 8.9 ± 0.96 14.0 ± 1.34 10.7 ± 0.99 10.4 ± 1.61 8.2 ± 1.35 11.3 ± 1.90 7.3 ± 1.55
miR-208b 0.22 ± 0.04 0.13 ± 0.03* 0.17 ± 0.03 0.12 ± 0.03* 0.23 ± 0.06 0.17 ± 0.02 0.22 ± 0.07 0.24 ± 0.08 0.23 ± 0.03 0.17 ± 0.03 0.14 ± 0.02 0.16 ± 0.03
miR-216a ND ND ND
miR-219 0.06 ± 0.01 0.05 ± 0.01 0.05 ± 0.01 0.04 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 0.06 ± 0.01 0.07 ± 0.01 0.04 ± 0.01 0.05 (0.01) 0.06 ± 0.01 0.06 ± 0.01
miR-221 0.27 ± 0.02 0.31 ± 0.04 0.29 ± 0.03 0.24 ± 0.01 0.13 ± 0.01 0.16 ± 0.02 0.08 ± 0.69 0.15 ± 0.02 0.15 ± 0.07 0.12 ± 0.04 0.12 ± 0.05 0.12 ± 0.01
miR-378 2.84 ± 0.30 2.48 ± 0.31 2.85 ± 0.49 2.54 ± 0.17 3.34 ± 0.41 4.08 ± 0.72 3.90 ± 0.56 3.73 ± 0.50 3.20 ± 1.03 3.05 ± 0.1 3.25 ± 0.45 2.98 ± 0.56
miR-532 0.53 ± 0.08 0.61 ± 0.08 0.64 ± 0.08* 0.69 ± 0.08* 0.85 ± 0.57 0.77 ± 0.47 0.57 ± 0.28 0.86 ± 0.57 0.69 ± 0.05 0.58 ± 0.06 0.53 ± 0.08 0.50 ± 0.09
miR-542 0.04 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01
miR-628 0.42 ± 0.03 0.39 ± 0.02 0.39 ± 0.04 0.34 ± 0.03 0.33 ± 0.06 0.34 ± 0.06 0.32 ± 0.05 0.29 ± 0.05 0.47 ± 0.02 0.42 ± 0.02 0.49 ± 0.04 0.41 ± 0.02

The relative concentrations of the circulating miRNAs were normalized to the Let-7d/g/i and presented as the mean ± SEM. miRNAs were obtained from plasma samples at baseline (Pre), immediately after exercise (0 h), after 1 h of recovery (1 h), after 24 h of recovery (24 h). *p < 0.05 compared to Pre; p < 0.05 compared to 0 h; p < 0.05 compared to 1 h. ND, non-detected values. Values obtained from 15 subjects separately in each of the three groups.